nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—DHFR—Methotrexate—multiple sclerosis	0.235	0.304	CbGbCtD
Trimethoprim—TYMS—Methotrexate—multiple sclerosis	0.164	0.212	CbGbCtD
Trimethoprim—ABCB1—Methylprednisolone—multiple sclerosis	0.0414	0.0535	CbGbCtD
Trimethoprim—CYP3A4—Fingolimod—multiple sclerosis	0.0385	0.0498	CbGbCtD
Trimethoprim—ABCB1—Mitoxantrone—multiple sclerosis	0.0302	0.039	CbGbCtD
Trimethoprim—ABCB1—Betamethasone—multiple sclerosis	0.0269	0.0348	CbGbCtD
Trimethoprim—ABCB1—Prednisolone—multiple sclerosis	0.0265	0.0343	CbGbCtD
Trimethoprim—ABCB1—Prednisone—multiple sclerosis	0.0251	0.0324	CbGbCtD
Trimethoprim—CYP3A4—Methylprednisolone—multiple sclerosis	0.0248	0.0321	CbGbCtD
Trimethoprim—CYP2C8—Dexamethasone—multiple sclerosis	0.0231	0.0299	CbGbCtD
Trimethoprim—CYP3A4—Triamcinolone—multiple sclerosis	0.0188	0.0243	CbGbCtD
Trimethoprim—CYP3A4—Mitoxantrone—multiple sclerosis	0.0181	0.0234	CbGbCtD
Trimethoprim—CYP2C9—Dexamethasone—multiple sclerosis	0.0161	0.0209	CbGbCtD
Trimethoprim—CYP3A4—Betamethasone—multiple sclerosis	0.0161	0.0208	CbGbCtD
Trimethoprim—CYP3A4—Prednisolone—multiple sclerosis	0.0159	0.0206	CbGbCtD
Trimethoprim—ABCB1—Dexamethasone—multiple sclerosis	0.0156	0.0202	CbGbCtD
Trimethoprim—CYP3A4—Prednisone—multiple sclerosis	0.015	0.0194	CbGbCtD
Trimethoprim—ABCB1—Methotrexate—multiple sclerosis	0.0126	0.0163	CbGbCtD
Trimethoprim—CYP3A4—Dexamethasone—multiple sclerosis	0.00938	0.0121	CbGbCtD
Trimethoprim—DHFR—Nucleotide Metabolism—SRM—multiple sclerosis	0.00485	0.129	CbGpPWpGaD
Trimethoprim—DHFR—Nucleotide Metabolism—RRM1—multiple sclerosis	0.00259	0.069	CbGpPWpGaD
Trimethoprim—DHFR—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00167	0.0443	CbGpPWpGaD
Trimethoprim—TYMS—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.00145	0.0387	CbGpPWpGaD
Trimethoprim—DHFR—E2F transcription factor network—RRM1—multiple sclerosis	0.000883	0.0235	CbGpPWpGaD
Trimethoprim—TYMS—E2F transcription factor network—RRM1—multiple sclerosis	0.00077	0.0205	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000767	0.0204	CbGpPWpGaD
Trimethoprim—TYMS—Nucleotide metabolism—RRM1—multiple sclerosis	0.00073	0.0194	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—RRM1—multiple sclerosis	0.000669	0.0178	CbGpPWpGaD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000578	0.0154	CbGpPWpGaD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000578	0.0154	CbGpPWpGaD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00054	0.0144	CbGpPWpGaD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00054	0.0144	CbGpPWpGaD
Trimethoprim—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000421	0.0112	CbGpPWpGaD
Trimethoprim—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000421	0.0112	CbGpPWpGaD
Trimethoprim—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000415	0.0111	CbGpPWpGaD
Trimethoprim—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000415	0.0111	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—IL4—multiple sclerosis	0.000391	0.0104	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000357	0.0095	CbGpPWpGaD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000356	0.00948	CbGpPWpGaD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000356	0.00948	CbGpPWpGaD
Trimethoprim—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000343	0.00912	CbGpPWpGaD
Trimethoprim—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000343	0.00912	CbGpPWpGaD
Trimethoprim—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000341	0.00909	CbGpPWpGaD
Trimethoprim—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000341	0.00909	CbGpPWpGaD
Trimethoprim—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000338	0.009	CbGpPWpGaD
Trimethoprim—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000338	0.009	CbGpPWpGaD
Trimethoprim—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000329	0.00876	CbGpPWpGaD
Trimethoprim—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000315	0.00839	CbGpPWpGaD
Trimethoprim—TYMS—Azacitidine—Cladribine—multiple sclerosis	0.000311	0.0491	CbGdCrCtD
Trimethoprim—DHFR—Folate Metabolism—ICAM1—multiple sclerosis	0.00031	0.00827	CbGpPWpGaD
Trimethoprim—DHFR—Folate Metabolism—CCL2—multiple sclerosis	0.000278	0.0074	CbGpPWpGaD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000278	0.0074	CbGpPWpGaD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000278	0.0074	CbGpPWpGaD
Trimethoprim—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000275	0.0015	CcSEcCtD
Trimethoprim—Convulsion—Prednisolone—multiple sclerosis	0.000272	0.00148	CcSEcCtD
Trimethoprim—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000271	0.00148	CcSEcCtD
Trimethoprim—Eosinophilia—Methotrexate—multiple sclerosis	0.000271	0.00148	CcSEcCtD
Trimethoprim—Pancreatitis—Methotrexate—multiple sclerosis	0.000268	0.00146	CcSEcCtD
Trimethoprim—Constipation—Mitoxantrone—multiple sclerosis	0.000267	0.00146	CcSEcCtD
Trimethoprim—Diarrhoea—Azathioprine—multiple sclerosis	0.000264	0.00144	CcSEcCtD
Trimethoprim—Angioedema—Triamcinolone—multiple sclerosis	0.000263	0.00144	CcSEcCtD
Trimethoprim—Angioedema—Methylprednisolone—multiple sclerosis	0.000263	0.00144	CcSEcCtD
Trimethoprim—Erythema—Dexamethasone—multiple sclerosis	0.000262	0.00143	CcSEcCtD
Trimethoprim—Erythema—Betamethasone—multiple sclerosis	0.000262	0.00143	CcSEcCtD
Trimethoprim—Hallucination—Prednisone—multiple sclerosis	0.00026	0.00142	CcSEcCtD
Trimethoprim—Pancytopenia—Methotrexate—multiple sclerosis	0.000259	0.00142	CcSEcCtD
Trimethoprim—Vertigo—Triamcinolone—multiple sclerosis	0.000259	0.00142	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—ALB—multiple sclerosis	0.000259	0.00689	CbGpPWpGaD
Trimethoprim—Syncope—Triamcinolone—multiple sclerosis	0.000259	0.00141	CcSEcCtD
Trimethoprim—Vertigo—Methylprednisolone—multiple sclerosis	0.000258	0.00141	CcSEcCtD
Trimethoprim—Syncope—Methylprednisolone—multiple sclerosis	0.000258	0.00141	CcSEcCtD
Trimethoprim—Connective tissue disorder—Prednisone—multiple sclerosis	0.000257	0.00141	CcSEcCtD
Trimethoprim—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000257	0.0014	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000256	0.0014	CcSEcCtD
Trimethoprim—Neutropenia—Methotrexate—multiple sclerosis	0.000256	0.0014	CcSEcCtD
Trimethoprim—Dizziness—Azathioprine—multiple sclerosis	0.000255	0.00139	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000255	0.00139	CcSEcCtD
Trimethoprim—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000253	0.00138	CcSEcCtD
Trimethoprim—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000253	0.00138	CcSEcCtD
Trimethoprim—Shock—Prednisolone—multiple sclerosis	0.000252	0.00138	CcSEcCtD
Trimethoprim—Cough—Triamcinolone—multiple sclerosis	0.000252	0.00137	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—C4A—multiple sclerosis	0.00025	0.00666	CbGpPWpGaD
Trimethoprim—Convulsion—Triamcinolone—multiple sclerosis	0.00025	0.00136	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000249	0.00136	CcSEcCtD
Trimethoprim—Convulsion—Methylprednisolone—multiple sclerosis	0.000249	0.00136	CcSEcCtD
Trimethoprim—Urticaria—Mitoxantrone—multiple sclerosis	0.000248	0.00135	CcSEcCtD
Trimethoprim—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000247	0.00135	CcSEcCtD
Trimethoprim—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000247	0.00135	CcSEcCtD
Trimethoprim—Myalgia—Triamcinolone—multiple sclerosis	0.000245	0.00134	CcSEcCtD
Trimethoprim—Vomiting—Azathioprine—multiple sclerosis	0.000245	0.00134	CcSEcCtD
Trimethoprim—Pneumonia—Methotrexate—multiple sclerosis	0.000245	0.00134	CcSEcCtD
Trimethoprim—Arthralgia—Methylprednisolone—multiple sclerosis	0.000245	0.00134	CcSEcCtD
Trimethoprim—Myalgia—Methylprednisolone—multiple sclerosis	0.000245	0.00134	CcSEcCtD
Trimethoprim—Eye disorder—Prednisone—multiple sclerosis	0.000245	0.00134	CcSEcCtD
Trimethoprim—Anxiety—Methylprednisolone—multiple sclerosis	0.000244	0.00133	CcSEcCtD
Trimethoprim—Infestation—Methotrexate—multiple sclerosis	0.000244	0.00133	CcSEcCtD
Trimethoprim—Infestation NOS—Methotrexate—multiple sclerosis	0.000244	0.00133	CcSEcCtD
Trimethoprim—Rash—Azathioprine—multiple sclerosis	0.000243	0.00133	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000243	0.00133	CcSEcCtD
Trimethoprim—Dermatitis—Azathioprine—multiple sclerosis	0.000243	0.00133	CcSEcCtD
Trimethoprim—Depression—Methotrexate—multiple sclerosis	0.000243	0.00133	CcSEcCtD
Trimethoprim—Headache—Azathioprine—multiple sclerosis	0.000242	0.00132	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000242	0.00132	CcSEcCtD
Trimethoprim—Renal failure—Methotrexate—multiple sclerosis	0.000239	0.00131	CcSEcCtD
Trimethoprim—Angioedema—Dexamethasone—multiple sclerosis	0.000239	0.00131	CcSEcCtD
Trimethoprim—Angioedema—Betamethasone—multiple sclerosis	0.000239	0.00131	CcSEcCtD
Trimethoprim—Stomatitis—Methotrexate—multiple sclerosis	0.000237	0.0013	CcSEcCtD
Trimethoprim—Confusional state—Methylprednisolone—multiple sclerosis	0.000237	0.00129	CcSEcCtD
Trimethoprim—Immune system disorder—Prednisone—multiple sclerosis	0.000236	0.00129	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—IFNG—multiple sclerosis	0.000236	0.00629	CbGpPWpGaD
Trimethoprim—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000235	0.00129	CcSEcCtD
Trimethoprim—Vertigo—Dexamethasone—multiple sclerosis	0.000235	0.00128	CcSEcCtD
Trimethoprim—Vertigo—Betamethasone—multiple sclerosis	0.000235	0.00128	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000235	0.00128	CcSEcCtD
Trimethoprim—Syncope—Dexamethasone—multiple sclerosis	0.000235	0.00128	CcSEcCtD
Trimethoprim—Syncope—Betamethasone—multiple sclerosis	0.000235	0.00128	CcSEcCtD
Trimethoprim—Haematuria—Methotrexate—multiple sclerosis	0.000232	0.00127	CcSEcCtD
Trimethoprim—Shock—Triamcinolone—multiple sclerosis	0.000231	0.00126	CcSEcCtD
Trimethoprim—Insomnia—Prednisolone—multiple sclerosis	0.000231	0.00126	CcSEcCtD
Trimethoprim—Shock—Methylprednisolone—multiple sclerosis	0.000231	0.00126	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00023	0.00126	CcSEcCtD
Trimethoprim—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00023	0.00126	CcSEcCtD
Trimethoprim—Loss of consciousness—Betamethasone—multiple sclerosis	0.00023	0.00126	CcSEcCtD
Trimethoprim—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00023	0.00126	CcSEcCtD
Trimethoprim—Epistaxis—Methotrexate—multiple sclerosis	0.00023	0.00126	CcSEcCtD
Trimethoprim—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00023	0.00126	CcSEcCtD
Trimethoprim—Mental disorder—Prednisone—multiple sclerosis	0.000229	0.00125	CcSEcCtD
Trimethoprim—Nausea—Azathioprine—multiple sclerosis	0.000229	0.00125	CcSEcCtD
Trimethoprim—Skin disorder—Methylprednisolone—multiple sclerosis	0.000228	0.00125	CcSEcCtD
Trimethoprim—Erythema—Prednisone—multiple sclerosis	0.000228	0.00124	CcSEcCtD
Trimethoprim—Malnutrition—Prednisone—multiple sclerosis	0.000228	0.00124	CcSEcCtD
Trimethoprim—Agranulocytosis—Methotrexate—multiple sclerosis	0.000227	0.00124	CcSEcCtD
Trimethoprim—Convulsion—Dexamethasone—multiple sclerosis	0.000227	0.00124	CcSEcCtD
Trimethoprim—Convulsion—Betamethasone—multiple sclerosis	0.000227	0.00124	CcSEcCtD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000226	0.00602	CbGpPWpGaD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000226	0.00602	CbGpPWpGaD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000223	0.00594	CbGpPWpGaD
Trimethoprim—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000223	0.00594	CbGpPWpGaD
Trimethoprim—Myalgia—Dexamethasone—multiple sclerosis	0.000223	0.00122	CcSEcCtD
Trimethoprim—Myalgia—Betamethasone—multiple sclerosis	0.000223	0.00122	CcSEcCtD
Trimethoprim—Anxiety—Dexamethasone—multiple sclerosis	0.000222	0.00121	CcSEcCtD
Trimethoprim—Anxiety—Betamethasone—multiple sclerosis	0.000222	0.00121	CcSEcCtD
Trimethoprim—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000216	0.00118	CcSEcCtD
Trimethoprim—Urethral disorder—Methotrexate—multiple sclerosis	0.000214	0.00117	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000214	0.00117	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000214	0.00117	CcSEcCtD
Trimethoprim—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000213	0.00117	CcSEcCtD
Trimethoprim—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000213	0.00117	CcSEcCtD
Trimethoprim—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000213	0.00117	CcSEcCtD
Trimethoprim—Insomnia—Triamcinolone—multiple sclerosis	0.000213	0.00116	CcSEcCtD
Trimethoprim—Insomnia—Methylprednisolone—multiple sclerosis	0.000212	0.00116	CcSEcCtD
Trimethoprim—Feeling abnormal—Prednisolone—multiple sclerosis	0.000211	0.00115	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—IL1B—multiple sclerosis	0.000211	0.00561	CbGpPWpGaD
Trimethoprim—Shock—Dexamethasone—multiple sclerosis	0.00021	0.00115	CcSEcCtD
Trimethoprim—Shock—Betamethasone—multiple sclerosis	0.00021	0.00115	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—IL2—multiple sclerosis	0.00021	0.00559	CbGpPWpGaD
Trimethoprim—Dyspnoea—Triamcinolone—multiple sclerosis	0.00021	0.00115	CcSEcCtD
Trimethoprim—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000209	0.00114	CcSEcCtD
Trimethoprim—Nervous system disorder—Betamethasone—multiple sclerosis	0.000209	0.00114	CcSEcCtD
Trimethoprim—Agitation—Prednisone—multiple sclerosis	0.000209	0.00114	CcSEcCtD
Trimethoprim—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000209	0.00114	CcSEcCtD
Trimethoprim—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000209	0.00114	CcSEcCtD
Trimethoprim—Angioedema—Prednisone—multiple sclerosis	0.000208	0.00114	CcSEcCtD
Trimethoprim—Dyspepsia—Triamcinolone—multiple sclerosis	0.000207	0.00113	CcSEcCtD
Trimethoprim—Erythema multiforme—Methotrexate—multiple sclerosis	0.000207	0.00113	CcSEcCtD
Trimethoprim—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000207	0.00113	CcSEcCtD
Trimethoprim—Vertigo—Prednisone—multiple sclerosis	0.000205	0.00112	CcSEcCtD
Trimethoprim—Eye disorder—Methotrexate—multiple sclerosis	0.000204	0.00112	CcSEcCtD
Trimethoprim—Syncope—Prednisone—multiple sclerosis	0.000204	0.00112	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	0.000204	0.00543	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	0.000204	0.00543	CbGpPWpGaD
Trimethoprim—Tinnitus—Methotrexate—multiple sclerosis	0.000204	0.00111	CcSEcCtD
Trimethoprim—Anorexia—Betamethasone—multiple sclerosis	0.000204	0.00111	CcSEcCtD
Trimethoprim—Anorexia—Dexamethasone—multiple sclerosis	0.000204	0.00111	CcSEcCtD
Trimethoprim—Urticaria—Prednisolone—multiple sclerosis	0.000203	0.00111	CcSEcCtD
Trimethoprim—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000203	0.0054	CbGpPWpGaD
Trimethoprim—Loss of consciousness—Prednisone—multiple sclerosis	0.0002	0.00109	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.0002	0.0315	CbGdCrCtD
Trimethoprim—Vomiting—Mitoxantrone—multiple sclerosis	0.000198	0.00108	CcSEcCtD
Trimethoprim—Immune system disorder—Methotrexate—multiple sclerosis	0.000198	0.00108	CcSEcCtD
Trimethoprim—Convulsion—Prednisone—multiple sclerosis	0.000197	0.00108	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Methylprednisolone—multiple sclerosis	0.000197	0.0311	CbGdCrCtD
Trimethoprim—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000197	0.00108	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.000197	0.031	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Betamethasone—multiple sclerosis	0.000197	0.031	CbGdCrCtD
Trimethoprim—Rash—Mitoxantrone—multiple sclerosis	0.000197	0.00107	CcSEcCtD
Trimethoprim—Dermatitis—Mitoxantrone—multiple sclerosis	0.000196	0.00107	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000195	0.0052	CbGpPWpGaD
Trimethoprim—Headache—Mitoxantrone—multiple sclerosis	0.000195	0.00107	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Methylprednisolone—multiple sclerosis	0.000195	0.0308	CbGdCrCtD
Trimethoprim—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000195	0.00106	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000195	0.00106	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Dexamethasone—multiple sclerosis	0.000194	0.0306	CbGdCrCtD
Trimethoprim—TYMS—Flunisolide—Betamethasone—multiple sclerosis	0.000194	0.0306	CbGdCrCtD
Trimethoprim—Arthralgia—Prednisone—multiple sclerosis	0.000194	0.00106	CcSEcCtD
Trimethoprim—Myalgia—Prednisone—multiple sclerosis	0.000194	0.00106	CcSEcCtD
Trimethoprim—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000194	0.00106	CcSEcCtD
Trimethoprim—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000193	0.00106	CcSEcCtD
Trimethoprim—Anxiety—Prednisone—multiple sclerosis	0.000193	0.00106	CcSEcCtD
Trimethoprim—Insomnia—Betamethasone—multiple sclerosis	0.000193	0.00106	CcSEcCtD
Trimethoprim—Insomnia—Dexamethasone—multiple sclerosis	0.000193	0.00106	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000193	0.00105	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.000192	0.0303	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Dexamethasone—multiple sclerosis	0.000192	0.0303	CbGdCrCtD
Trimethoprim—TYMS—Triamcinolone—Betamethasone—multiple sclerosis	0.000192	0.0303	CbGdCrCtD
Trimethoprim—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000192	0.00105	CcSEcCtD
Trimethoprim—Mental disorder—Methotrexate—multiple sclerosis	0.000192	0.00105	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00019	0.03	CbGdCrCtD
Trimethoprim—Erythema—Methotrexate—multiple sclerosis	0.00019	0.00104	CcSEcCtD
Trimethoprim—Malnutrition—Methotrexate—multiple sclerosis	0.00019	0.00104	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Triamcinolone—multiple sclerosis	0.00019	0.0299	CbGdCrCtD
Trimethoprim—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000189	0.00503	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Prednisolone—multiple sclerosis	0.000189	0.00103	CcSEcCtD
Trimethoprim—Dyspepsia—Dexamethasone—multiple sclerosis	0.000188	0.00103	CcSEcCtD
Trimethoprim—Dyspepsia—Betamethasone—multiple sclerosis	0.000188	0.00103	CcSEcCtD
Trimethoprim—TYMS—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000187	0.0295	CbGdCrCtD
Trimethoprim—TYMS—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000187	0.0295	CbGdCrCtD
Trimethoprim—Urticaria—Triamcinolone—multiple sclerosis	0.000187	0.00102	CcSEcCtD
Trimethoprim—Urticaria—Methylprednisolone—multiple sclerosis	0.000187	0.00102	CcSEcCtD
Trimethoprim—Body temperature increased—Triamcinolone—multiple sclerosis	0.000186	0.00102	CcSEcCtD
Trimethoprim—Anaphylactic shock—Prednisone—multiple sclerosis	0.000186	0.00102	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	0.000186	0.00494	CbGpPWpGaD
Trimethoprim—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000186	0.00101	CcSEcCtD
Trimethoprim—Decreased appetite—Betamethasone—multiple sclerosis	0.000186	0.00101	CcSEcCtD
Trimethoprim—Decreased appetite—Dexamethasone—multiple sclerosis	0.000186	0.00101	CcSEcCtD
Trimethoprim—Nausea—Mitoxantrone—multiple sclerosis	0.000185	0.00101	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000184	0.00101	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000184	0.00101	CcSEcCtD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000183	0.00488	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000183	0.00488	CbGpPWpGaD
Trimethoprim—TYMS—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000183	0.0289	CbGdCrCtD
Trimethoprim—Shock—Prednisone—multiple sclerosis	0.000183	0.000999	CcSEcCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisone—multiple sclerosis	0.000182	0.0288	CbGdCrCtD
Trimethoprim—Nervous system disorder—Prednisone—multiple sclerosis	0.000182	0.000996	CcSEcCtD
Trimethoprim—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000181	0.00483	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000181	0.00483	CbGpPWpGaD
Trimethoprim—Skin disorder—Prednisone—multiple sclerosis	0.000181	0.000987	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisone—multiple sclerosis	0.00018	0.0284	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Methylprednisolone—multiple sclerosis	0.00018	0.0284	CbGdCrCtD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000179	0.00476	CbGpPWpGaD
Trimethoprim—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000179	0.00476	CbGpPWpGaD
Trimethoprim—TYMS—Triamcinolone—Prednisone—multiple sclerosis	0.000178	0.0281	CbGdCrCtD
Trimethoprim—TYMS—Clobetasol propionate—Prednisolone—multiple sclerosis	0.000178	0.0281	CbGdCrCtD
Trimethoprim—Anorexia—Prednisone—multiple sclerosis	0.000177	0.000968	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Betamethasone—multiple sclerosis	0.000177	0.0279	CbGdCrCtD
Trimethoprim—TYMS—Diflorasone—Dexamethasone—multiple sclerosis	0.000177	0.0279	CbGdCrCtD
Trimethoprim—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000177	0.0047	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Betamethasone—multiple sclerosis	0.000176	0.000961	CcSEcCtD
Trimethoprim—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000176	0.000961	CcSEcCtD
Trimethoprim—TYMS—Flunisolide—Prednisolone—multiple sclerosis	0.000176	0.0277	CbGdCrCtD
Trimethoprim—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	0.000175	0.00466	CbGpPWpGaD
Trimethoprim—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000175	0.000954	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000175	0.000954	CcSEcCtD
Trimethoprim—TYMS—Triamcinolone—Prednisolone—multiple sclerosis	0.000174	0.0274	CbGdCrCtD
Trimethoprim—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000173	0.000947	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Triamcinolone—multiple sclerosis	0.000173	0.0273	CbGdCrCtD
Trimethoprim—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000173	0.000945	CcSEcCtD
Trimethoprim—Vertigo—Methotrexate—multiple sclerosis	0.000171	0.000935	CcSEcCtD
Trimethoprim—Leukopenia—Methotrexate—multiple sclerosis	0.00017	0.000931	CcSEcCtD
Trimethoprim—Urticaria—Betamethasone—multiple sclerosis	0.00017	0.000927	CcSEcCtD
Trimethoprim—Urticaria—Dexamethasone—multiple sclerosis	0.00017	0.000927	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000169	0.000926	CcSEcCtD
Trimethoprim—Dizziness—Prednisolone—multiple sclerosis	0.000169	0.000924	CcSEcCtD
Trimethoprim—Body temperature increased—Dexamethasone—multiple sclerosis	0.000169	0.000922	CcSEcCtD
Trimethoprim—Body temperature increased—Betamethasone—multiple sclerosis	0.000169	0.000922	CcSEcCtD
Trimethoprim—Abdominal pain—Betamethasone—multiple sclerosis	0.000169	0.000922	CcSEcCtD
Trimethoprim—Abdominal pain—Dexamethasone—multiple sclerosis	0.000169	0.000922	CcSEcCtD
Trimethoprim—Insomnia—Prednisone—multiple sclerosis	0.000168	0.000919	CcSEcCtD
Trimethoprim—Pruritus—Triamcinolone—multiple sclerosis	0.000166	0.00091	CcSEcCtD
Trimethoprim—Cough—Methotrexate—multiple sclerosis	0.000166	0.000908	CcSEcCtD
Trimethoprim—Pruritus—Methylprednisolone—multiple sclerosis	0.000166	0.000908	CcSEcCtD
Trimethoprim—Convulsion—Methotrexate—multiple sclerosis	0.000165	0.000901	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisone—multiple sclerosis	0.000164	0.0259	CbGdCrCtD
Trimethoprim—Dyspepsia—Prednisone—multiple sclerosis	0.000164	0.000894	CcSEcCtD
Trimethoprim—Myalgia—Methotrexate—multiple sclerosis	0.000162	0.000886	CcSEcCtD
Trimethoprim—Arthralgia—Methotrexate—multiple sclerosis	0.000162	0.000886	CcSEcCtD
Trimethoprim—Decreased appetite—Prednisone—multiple sclerosis	0.000162	0.000883	CcSEcCtD
Trimethoprim—Rash—Prednisolone—multiple sclerosis	0.000161	0.000881	CcSEcCtD
Trimethoprim—Dermatitis—Prednisolone—multiple sclerosis	0.000161	0.000881	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000161	0.00088	CcSEcCtD
Trimethoprim—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000161	0.000878	CcSEcCtD
Trimethoprim—TYMS—Diflorasone—Prednisolone—multiple sclerosis	0.00016	0.0253	CbGdCrCtD
Trimethoprim—Headache—Prednisolone—multiple sclerosis	0.00016	0.000876	CcSEcCtD
Trimethoprim—Constipation—Prednisone—multiple sclerosis	0.000159	0.000869	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	0.000159	0.00423	CbGpPWpGaD
Trimethoprim—TYMS—Budesonide—Methylprednisolone—multiple sclerosis	0.000158	0.0249	CbGdCrCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000157	0.00418	CbGpPWpGaD
Trimethoprim—Confusional state—Methotrexate—multiple sclerosis	0.000157	0.000856	CcSEcCtD
Trimethoprim—Dizziness—Triamcinolone—multiple sclerosis	0.000156	0.00085	CcSEcCtD
Trimethoprim—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000155	0.000849	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Betamethasone—multiple sclerosis	0.000155	0.0245	CbGdCrCtD
Trimethoprim—TYMS—Budesonide—Dexamethasone—multiple sclerosis	0.000155	0.0245	CbGdCrCtD
Trimethoprim—Dizziness—Methylprednisolone—multiple sclerosis	0.000155	0.000848	CcSEcCtD
Trimethoprim—Feeling abnormal—Prednisone—multiple sclerosis	0.000153	0.000837	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—TNF—multiple sclerosis	0.000153	0.00407	CbGpPWpGaD
Trimethoprim—Nervous system disorder—Methotrexate—multiple sclerosis	0.000152	0.000833	CcSEcCtD
Trimethoprim—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000152	0.000831	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000152	0.000831	CcSEcCtD
Trimethoprim—Nausea—Prednisolone—multiple sclerosis	0.000152	0.00083	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Triamcinolone—multiple sclerosis	0.000152	0.0239	CbGdCrCtD
Trimethoprim—DHFR—E2F transcription factor network—MYC—multiple sclerosis	0.000151	0.00403	CbGpPWpGaD
Trimethoprim—Pruritus—Dexamethasone—multiple sclerosis	0.000151	0.000825	CcSEcCtD
Trimethoprim—Pruritus—Betamethasone—multiple sclerosis	0.000151	0.000825	CcSEcCtD
Trimethoprim—Skin disorder—Methotrexate—multiple sclerosis	0.000151	0.000825	CcSEcCtD
Trimethoprim—Vomiting—Triamcinolone—multiple sclerosis	0.00015	0.000817	CcSEcCtD
Trimethoprim—Vomiting—Methylprednisolone—multiple sclerosis	0.000149	0.000816	CcSEcCtD
Trimethoprim—Rash—Triamcinolone—multiple sclerosis	0.000148	0.000811	CcSEcCtD
Trimethoprim—Dermatitis—Triamcinolone—multiple sclerosis	0.000148	0.00081	CcSEcCtD
Trimethoprim—Anorexia—Methotrexate—multiple sclerosis	0.000148	0.000809	CcSEcCtD
Trimethoprim—Rash—Methylprednisolone—multiple sclerosis	0.000148	0.000809	CcSEcCtD
Trimethoprim—Dermatitis—Methylprednisolone—multiple sclerosis	0.000148	0.000808	CcSEcCtD
Trimethoprim—Urticaria—Prednisone—multiple sclerosis	0.000148	0.000807	CcSEcCtD
Trimethoprim—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000148	0.00393	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000148	0.00393	CbGpPWpGaD
Trimethoprim—Headache—Triamcinolone—multiple sclerosis	0.000147	0.000805	CcSEcCtD
Trimethoprim—Headache—Methylprednisolone—multiple sclerosis	0.000147	0.000804	CcSEcCtD
Trimethoprim—Abdominal pain—Prednisone—multiple sclerosis	0.000147	0.000803	CcSEcCtD
Trimethoprim—Body temperature increased—Prednisone—multiple sclerosis	0.000147	0.000803	CcSEcCtD
Trimethoprim—Diarrhoea—Betamethasone—multiple sclerosis	0.000146	0.000798	CcSEcCtD
Trimethoprim—Diarrhoea—Dexamethasone—multiple sclerosis	0.000146	0.000798	CcSEcCtD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000146	0.00387	CbGpPWpGaD
Trimethoprim—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000146	0.00387	CbGpPWpGaD
Trimethoprim—TYMS—Budesonide—Prednisone—multiple sclerosis	0.000144	0.0227	CbGdCrCtD
Trimethoprim—DHFR—Metabolism—SRM—multiple sclerosis	0.000142	0.00379	CbGpPWpGaD
Trimethoprim—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000142	0.000773	CcSEcCtD
Trimethoprim—Dizziness—Betamethasone—multiple sclerosis	0.000141	0.000771	CcSEcCtD
Trimethoprim—Dizziness—Dexamethasone—multiple sclerosis	0.000141	0.000771	CcSEcCtD
Trimethoprim—TYMS—Budesonide—Prednisolone—multiple sclerosis	0.000141	0.0222	CbGdCrCtD
Trimethoprim—Insomnia—Methotrexate—multiple sclerosis	0.000141	0.000768	CcSEcCtD
Trimethoprim—Nausea—Triamcinolone—multiple sclerosis	0.00014	0.000764	CcSEcCtD
Trimethoprim—Nausea—Methylprednisolone—multiple sclerosis	0.000139	0.000762	CcSEcCtD
Trimethoprim—Dyspnoea—Methotrexate—multiple sclerosis	0.000139	0.000757	CcSEcCtD
Trimethoprim—TYMS—Danazol—Prednisone—multiple sclerosis	0.000138	0.0218	CbGdCrCtD
Trimethoprim—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	0.000138	0.00367	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Prednisone—multiple sclerosis	0.000137	0.000748	CcSEcCtD
Trimethoprim—Dyspepsia—Methotrexate—multiple sclerosis	0.000137	0.000747	CcSEcCtD
Trimethoprim—Vomiting—Betamethasone—multiple sclerosis	0.000136	0.000742	CcSEcCtD
Trimethoprim—Vomiting—Dexamethasone—multiple sclerosis	0.000136	0.000742	CcSEcCtD
Trimethoprim—Decreased appetite—Methotrexate—multiple sclerosis	0.000135	0.000738	CcSEcCtD
Trimethoprim—Rash—Dexamethasone—multiple sclerosis	0.000135	0.000735	CcSEcCtD
Trimethoprim—Rash—Betamethasone—multiple sclerosis	0.000135	0.000735	CcSEcCtD
Trimethoprim—Dermatitis—Dexamethasone—multiple sclerosis	0.000134	0.000735	CcSEcCtD
Trimethoprim—Dermatitis—Betamethasone—multiple sclerosis	0.000134	0.000735	CcSEcCtD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	0.000134	0.00358	CbGpPWpGaD
Trimethoprim—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000134	0.000733	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—CD28—multiple sclerosis	0.000134	0.00356	CbGpPWpGaD
Trimethoprim—Headache—Dexamethasone—multiple sclerosis	0.000134	0.000731	CcSEcCtD
Trimethoprim—Headache—Betamethasone—multiple sclerosis	0.000134	0.000731	CcSEcCtD
Trimethoprim—TYMS—E2F transcription factor network—MYC—multiple sclerosis	0.000132	0.00352	CbGpPWpGaD
Trimethoprim—DHFR—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	0.000132	0.0035	CbGpPWpGaD
Trimethoprim—Pruritus—Prednisone—multiple sclerosis	0.000132	0.000719	CcSEcCtD
Trimethoprim—TYMS—Circadian rythm related genes—FAS—multiple sclerosis	0.000129	0.00343	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	0.000128	0.00341	CbGpPWpGaD
Trimethoprim—Feeling abnormal—Methotrexate—multiple sclerosis	0.000128	0.0007	CcSEcCtD
Trimethoprim—Diarrhoea—Prednisone—multiple sclerosis	0.000127	0.000695	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000127	0.000694	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	0.000127	0.00338	CbGpPWpGaD
Trimethoprim—Nausea—Dexamethasone—multiple sclerosis	0.000127	0.000693	CcSEcCtD
Trimethoprim—Nausea—Betamethasone—multiple sclerosis	0.000127	0.000693	CcSEcCtD
Trimethoprim—TYMS—Metabolism—SRM—multiple sclerosis	0.000124	0.00331	CbGpPWpGaD
Trimethoprim—Urticaria—Methotrexate—multiple sclerosis	0.000123	0.000674	CcSEcCtD
Trimethoprim—DHFR—Folate Metabolism—IL6—multiple sclerosis	0.000123	0.00329	CbGpPWpGaD
Trimethoprim—Dizziness—Prednisone—multiple sclerosis	0.000123	0.000672	CcSEcCtD
Trimethoprim—Body temperature increased—Methotrexate—multiple sclerosis	0.000123	0.000671	CcSEcCtD
Trimethoprim—Abdominal pain—Methotrexate—multiple sclerosis	0.000123	0.000671	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—CD40—multiple sclerosis	0.000122	0.00325	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.00012	0.00321	CbGpPWpGaD
Trimethoprim—Vomiting—Prednisone—multiple sclerosis	0.000118	0.000646	CcSEcCtD
Trimethoprim—Rash—Prednisone—multiple sclerosis	0.000117	0.000641	CcSEcCtD
Trimethoprim—Dermatitis—Prednisone—multiple sclerosis	0.000117	0.00064	CcSEcCtD
Trimethoprim—Headache—Prednisone—multiple sclerosis	0.000116	0.000636	CcSEcCtD
Trimethoprim—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000116	0.0031	CbGpPWpGaD
Trimethoprim—TYMS—Retinoblastoma (RB) in Cancer—MYC—multiple sclerosis	0.000115	0.00306	CbGpPWpGaD
Trimethoprim—Hypersensitivity—Methotrexate—multiple sclerosis	0.000114	0.000626	CcSEcCtD
Trimethoprim—Nausea—Prednisone—multiple sclerosis	0.00011	0.000603	CcSEcCtD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.00011	0.00293	CbGpPWpGaD
Trimethoprim—Pruritus—Methotrexate—multiple sclerosis	0.00011	0.000601	CcSEcCtD
Trimethoprim—DHFR—G1/S Transition—MYC—multiple sclerosis	0.00011	0.00293	CbGpPWpGaD
Trimethoprim—DHFR—Disease—GPC5—multiple sclerosis	0.00011	0.00292	CbGpPWpGaD
Trimethoprim—Diarrhoea—Methotrexate—multiple sclerosis	0.000106	0.000581	CcSEcCtD
Trimethoprim—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000106	0.00282	CbGpPWpGaD
Trimethoprim—Dizziness—Methotrexate—multiple sclerosis	0.000103	0.000561	CcSEcCtD
Trimethoprim—DHFR—Metabolism—CYP24A1—multiple sclerosis	0.0001	0.00267	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP27B1—multiple sclerosis	0.0001	0.00267	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	9.92e-05	0.00264	CbGpPWpGaD
Trimethoprim—Vomiting—Methotrexate—multiple sclerosis	9.88e-05	0.00054	CcSEcCtD
Trimethoprim—Rash—Methotrexate—multiple sclerosis	9.8e-05	0.000535	CcSEcCtD
Trimethoprim—Dermatitis—Methotrexate—multiple sclerosis	9.79e-05	0.000535	CcSEcCtD
Trimethoprim—Headache—Methotrexate—multiple sclerosis	9.73e-05	0.000532	CcSEcCtD
Trimethoprim—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.73e-05	0.00259	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.73e-05	0.00259	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.6e-05	0.00256	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.6e-05	0.00256	CbGpPWpGaD
Trimethoprim—TYMS—G1/S Transition—MYC—multiple sclerosis	9.59e-05	0.00255	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CD86—multiple sclerosis	9.55e-05	0.00254	CbGpPWpGaD
Trimethoprim—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.47e-05	0.00252	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL10—multiple sclerosis	9.37e-05	0.00249	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	9.37e-05	0.00249	CbGpPWpGaD
Trimethoprim—DHFR—Mitotic G1-G1/S phases—MYC—multiple sclerosis	9.26e-05	0.00247	CbGpPWpGaD
Trimethoprim—Nausea—Methotrexate—multiple sclerosis	9.23e-05	0.000504	CcSEcCtD
Trimethoprim—DHFR—Metabolism—GPC5—multiple sclerosis	9.18e-05	0.00244	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL4—multiple sclerosis	9.11e-05	0.00243	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	8.91e-05	0.00237	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP24A1—multiple sclerosis	8.75e-05	0.00233	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP27B1—multiple sclerosis	8.75e-05	0.00233	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—FAS—multiple sclerosis	8.4e-05	0.00224	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	8.35e-05	0.00222	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	8.26e-05	0.0022	CbGpPWpGaD
Trimethoprim—TYMS—Mitotic G1-G1/S phases—MYC—multiple sclerosis	8.08e-05	0.00215	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GPC5—multiple sclerosis	8.01e-05	0.00213	CbGpPWpGaD
Trimethoprim—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.71e-05	0.00205	CbGpPWpGaD
Trimethoprim—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	7.68e-05	0.00204	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—RRM1—multiple sclerosis	7.6e-05	0.00202	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	7.54e-05	0.00201	CbGpPWpGaD
Trimethoprim—DHFR—Disease—RPL5—multiple sclerosis	7.12e-05	0.0019	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—CD80—multiple sclerosis	6.97e-05	0.00186	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.96e-05	0.00185	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.96e-05	0.00185	CbGpPWpGaD
Trimethoprim—DHFR—Disease—SLC11A1—multiple sclerosis	6.82e-05	0.00182	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—RRM1—multiple sclerosis	6.63e-05	0.00177	CbGpPWpGaD
Trimethoprim—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.25e-05	0.00166	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.2e-05	0.00165	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	6.12e-05	0.00163	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	6.11e-05	0.00163	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.03e-05	0.00161	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	5.99e-05	0.00159	CbGpPWpGaD
Trimethoprim—TYMS—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	5.7e-05	0.00152	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.67e-05	0.00151	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.67e-05	0.00151	CbGpPWpGaD
Trimethoprim—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.61e-05	0.00149	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.51e-05	0.00147	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD28—multiple sclerosis	5.45e-05	0.00145	CbGpPWpGaD
Trimethoprim—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.08e-05	0.00135	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.91e-05	0.00131	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.89e-05	0.0013	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.84e-05	0.00129	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.7e-05	0.00125	CbGpPWpGaD
Trimethoprim—TYMS—Circadian rythm related genes—IL6—multiple sclerosis	4.42e-05	0.00118	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SRM—multiple sclerosis	4.4e-05	0.00117	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—BCHE—multiple sclerosis	4.37e-05	0.00116	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.14e-05	0.0011	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.12e-05	0.0011	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.08e-05	0.00109	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD86—multiple sclerosis	3.89e-05	0.00104	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SRM—multiple sclerosis	3.83e-05	0.00102	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.82e-05	0.00102	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—BCHE—multiple sclerosis	3.81e-05	0.00101	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.72e-05	0.00099	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SRM—multiple sclerosis	3.58e-05	0.000954	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.57e-05	0.000949	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CCR5—multiple sclerosis	3.45e-05	0.000918	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—multiple sclerosis	3.4e-05	0.000904	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HLA-A—multiple sclerosis	3.36e-05	0.000895	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	3.32e-05	0.000885	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.32e-05	0.000884	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.29e-05	0.000875	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APOE—multiple sclerosis	3.14e-05	0.000835	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.1e-05	0.000826	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.1e-05	0.000826	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—multiple sclerosis	3.04e-05	0.000809	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.03e-05	0.000807	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MAPK1—multiple sclerosis	2.97e-05	0.000791	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—multiple sclerosis	2.96e-05	0.000789	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	2.9e-05	0.000772	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD80—multiple sclerosis	2.84e-05	0.000755	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.84e-05	0.000755	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.7e-05	0.000719	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.7e-05	0.000719	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—multiple sclerosis	2.65e-05	0.000706	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—APOE—multiple sclerosis	2.63e-05	0.0007	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MAPK1—multiple sclerosis	2.59e-05	0.00069	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.52e-05	0.000672	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.52e-05	0.000672	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GPC5—multiple sclerosis	2.47e-05	0.000658	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.47e-05	0.000657	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TYK2—multiple sclerosis	2.39e-05	0.000638	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SRM—multiple sclerosis	2.36e-05	0.000629	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.35e-05	0.000626	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.31e-05	0.000615	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—APOE—multiple sclerosis	2.29e-05	0.00061	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—POMC—multiple sclerosis	2.26e-05	0.000601	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.19e-05	0.000583	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD4—multiple sclerosis	2.17e-05	0.000577	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ALB—multiple sclerosis	2.06e-05	0.000548	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—RRM1—multiple sclerosis	2.05e-05	0.000545	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—POMC—multiple sclerosis	1.97e-05	0.000524	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.91e-05	0.000509	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.89e-05	0.000503	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.88e-05	0.000502	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.85e-05	0.000492	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.82e-05	0.000485	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ALB—multiple sclerosis	1.8e-05	0.000478	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.76e-05	0.000468	CbGpPWpGaD
Trimethoprim—DHFR—Disease—STAT3—multiple sclerosis	1.68e-05	0.000446	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.66e-05	0.000443	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.66e-05	0.000443	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.57e-05	0.000417	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—multiple sclerosis	1.56e-05	0.000415	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TGFB1—multiple sclerosis	1.55e-05	0.000414	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK1—multiple sclerosis	1.52e-05	0.000406	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.52e-05	0.000405	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.48e-05	0.000395	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.43e-05	0.00038	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.35e-05	0.000359	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.27e-05	0.000339	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.26e-05	0.000336	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.18e-05	0.000315	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BCHE—multiple sclerosis	1.18e-05	0.000313	CbGpPWpGaD
Trimethoprim—DHFR—Disease—IL6—multiple sclerosis	1.17e-05	0.000312	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.16e-05	0.000309	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000292	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APOE—multiple sclerosis	8.12e-06	0.000216	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.24e-06	0.000193	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APOE—multiple sclerosis	7.07e-06	0.000188	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—POMC—multiple sclerosis	6.97e-06	0.000186	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APOE—multiple sclerosis	6.61e-06	0.000176	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALB—multiple sclerosis	6.36e-06	0.000169	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—POMC—multiple sclerosis	6.08e-06	0.000162	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—POMC—multiple sclerosis	5.68e-06	0.000151	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALB—multiple sclerosis	5.54e-06	0.000148	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALB—multiple sclerosis	5.17e-06	0.000138	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APOE—multiple sclerosis	4.36e-06	0.000116	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—POMC—multiple sclerosis	3.74e-06	9.97e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALB—multiple sclerosis	3.41e-06	9.09e-05	CbGpPWpGaD
